Publicação científica trimestral do CREMERJ - volume 2 - número 2 - 2023

39 Med. Ciên. e Arte , Rio de Janeiro, v.2, n.2, p.25-41, abr-jun 2023 Hepatite alcoólica Bernardo da Cruz Junger de Carvalho et al. transplante de fígado como terapia de res- gate. Intervenções sociais e governamentais urgentes, com políticas de saúde pública e aumento de impostos na comercialização de bebidas, são necessárias para evitar o aumento do consumo abusivo de álcool. REFERÊNCIAS 1. Stein E, Cruz-Lemini M, Altamirano J, et al. Heavy daily alcohol intake at the population level predicts the weight of alcohol in cirrhosis burden worldwide. J Hepatol 2016; 65:998-1005. 2. Crabb DW, Bataller R, Chalasani NP, Kamath PS, Lucey M, Mathurin P et al. NIAAA Alcoholic Hepatitis Consortia. Standard Definitions and Common Data Elements for Clinical Trials in Patients with Alcoholic Hepatitis: Recommendation from the NIAAA Alcoholic Hepatitis Consortia. Gastroenterology. 2016 Apr;150 (4):785-90. 3. Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med. 2009 Jun 25; 360 (26):2758-69. 4. Sandahl TD, Jepsen P, Thomsen KL, Vilstrup H. Incidence and mortality of alcoholic hepatitis in Denmark 1999-2008: a nationwide population based cohort study. J Hepatol. 2011 Apr; 54(4):760-4. 5. Singal AK, Mathurin P. Diagnosis and treatment of alcohol-associated liver disease: a review. JAMA 2021;326:165-76. 6. Singal AK, Arsalan A, Dunn W, et al. Alcohol-associated liver disease in the United States is associated with severe forms of disease among young, females and Hispanics. Aliment Pharmacol Ther 2021;54:451-61. 7. Bloom PP, Fontana RJ. With alcohol as the fuel, COVID is the match: liver transplantation for alcohol- associated liver disease is increasing in the United States. Hepatology 2021;74:2948-51. 8. Cholankeril G, Goli K, Rana A, et al. Impact of COVID-19 pandemic on liver transplantation and alcohol- associated liver disease in the USA. Hepatology 2021; 74:3316-29. 9. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC . Excess weight risk factor for alcoholic liver disease. Hepatology. 1997 Jan; 25(1):108-11. 10. Katoonizadeh A, Laleman W, Verslype C, Wilmer A, Maleux G, Roskams T, Nevens F. Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study. 3. Gut. 2010 Nov; 59 (11):1561-9. 11. Arroyo V, Moreau R, Kamath PS, Jalan R, Ginès P, et al. Acute-on-chronic liver failure in cirrhosis. Nat Rev Dis Primers. 2016 Jun 9; 2:16041. 12. Ramon Bataller, Juan Pablo Arab, Vijay H Shah. Alcohol-Associated Hepatitis. N Engl J Med. 2022 Dec 29;387(26):2436-2448. 13. Helping Patients Who Drink Too Much: A Clinician’s Guide. US Department of Health and Human Services, National Institute of Health, National Institute on Alcohol Abuse and Alcoholism, 2005. 14. O'Shea RS, Dasarathy S, McCullough AJ; Practice Guideline Committee of the American Association for the Study of Liver Diseases. Alcoholic Liver Disease. Hepatology. 2010 Jan; 51(1):307-28. 15. European Association for the Study of Liver. EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol. 2012 Aug;57(2):399-420. 16. Mookerjee RP, Lackner C, Stauber R, Stadlbauer V, Deheragoda M, et al. The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis. J Hepatol. 2011 Nov; 55(5):1103-11. 17. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD; American Association for the Study of Liver Diseases. Liver biopsy. Hepatology. 2009 Mar; 49 (3):1017-44. 18. Dunne PDJ Forrest EH. Review article: recent insights into clinical decision-making in severe alcoholic hepatitis. Aliment Pharmacol Ther. 2017 Aug; 46(3):274-281.